Old Web
English
Sign In
Acemap
>
Paper
>
CD38-NAD+-Sirt1 axis In T cell immunotherapy.
CD38-NAD+-Sirt1 axis In T cell immunotherapy.
2019
Shilpak Chatterjee
Paramita Chakraborty
Shikhar Mehrotra
Keywords:
Immunotherapy
Cancer research
Chemistry
T cell
NAD+ kinase
CD38
Melanoma
t cell immunotherapy
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
8
References
2
Citations
NaN
KQI
[]